| TRADING CENTER |
| SCOLR Pharma, Inc. Licenses Dietary Supplements - PR Newswire | |
| SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and ... - PR Newswire |
| Last trade | Change/%change | P/E ratio | ||
|---|---|---|---|---|
| AMGN | Amgen Inc | 57.42 | 0.07 / 0.12% | 10.98 |
| GILD | Gilead Sciences Inc | 43.00 | -0.01 / -0.02% | 16.60 |
| CELG | Celgene Corporation | 56.38 | -0.42 / -0.74% | 67.93 |
| 2008 Revenue: | $958,000.0 | Headquarters: Bellevue, WA |
| Employees: | 17 | CEO: Stephen J. Turner |
| Net Income: | $-6,140,000.0 | Industry: Biotechnology |
| Market Cap: | $21.0 M | Website: www.scolr.com |
| Symbol | Price | Change/%Change | Prev. close | High | Low | Last Update | More Info |
|---|---|---|---|---|---|---|---|
| DDD | 0.55 | +0.04 / +7.84% | 0.51 | 0.55 | 0.52 | Profile Chart News |